Christopher Pannucci, MD
Plastic and Reconstructive Surgery · Spokane, WANPI 1083737738
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,029 of the $11,397 with a category attached, or 79.2%. Sientra, Inc. accounts for 71.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $9,358 and has fallen 90.2% since, to $913 in 2025.
Across 47 payments — averaging $242.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$8K
- RTI Surgical, Inc$2K
- AbbVie$927
- Davol Inc.$234
- Innovation Technologies Inc$169
- Revance Therapeutics, Inc.$142
- plus $306 from 4 others
Across 6 payments — averaging $7180.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$43K
What the payments were for
- Consulting fees$9,02979%
- Food & beverage$2,36821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 16 | $8,118 |
| RTI Surgical, Inc | 1 | $1,500 |
| AbbVie(2 entities) | 18 | $927 |
| Davol Inc. | 2 | $234 |
| Innovation Technologies Inc | 2 | $169 |
| Revance Therapeutics, Inc. | 2 | $142 |
| Mentor Worldwide LLC | 2 | $122 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $93 |
| Stryker | 2 | $67 |
| Motiva USA, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,397 in reported general payments places this provider in the 80th percentile of 63 plastic and reconstructive surgery providers in Washington.
See all plastic and reconstructive surgery providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 19 | $185 |
| Oxycodone Hcl | 18 | $82 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Spokane
- Janelle SousaSpokane$1K
- Lucy PetersonSpokane$0
- Vincent MuonekeBurien$84K
- Fredric SternBellevue$38K
- Srinivas SusarlaSeattle$32K
- Kristin TarbetBellevue$30K
- Javad SajanSeattle$21K
- Sepehr EgrariBellevue$19K
- Christopher BatesLaguna Beach$17K
- Joseph GrussSeattle$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.